当前位置: 首页 > 详情页

Epidemiology and risk factors of neurosurgical bacterial meningitis/encephalitis induced by carbapenem resistant Enterobacteriaceae

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Department of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, China [b]Department of Clinical Diagnosis Laboratory of Beijing Jishuitan Hospital, China
出处:
ISSN:

关键词: Carbapenem resistant Enterobacteriaceae Infection Meningitis/encephalitis Risk factors

摘要:
Objectives: This is a retrospective observational study conducted in one of the largest clinical center of neurosurgery in China. Our aim was to determine the epidemiological characteristics of carbapenem-resistant Enterobacteriaceae (CRE) related meningitis/encephalitis and to elucidate the risk factors for CRE neurosurgical infections. Patients and methods: We performed a retrospective study between January 2012 and December 2017 of patients who underwent neurosurgery. The medical records of each patient were reviewed, and 20 clinical variables on risk factors were extracted and evaluated by Multivariate logistic analysis for CRE-meningitis/encephalitis. Results: In 2012–2017, the positive rate of neurosurgical meningitis/encephalitis was 7.9% (2947/29605), Enterobacteriaceae accounted for 6.3% (185/2947) of all bacterial infections. Totally, 133 Enterobacteriaceae include 26 CRE isolates were available in this study. Of them, Univariate analysis showed that the risk factors of CRE meningitis were ventilator, bacteremia, Intensive Care Unit (ICU) admission, hospital acquired pneumonia and mortality attribute to infection. Multivariate logistic analysis showed that hospital acquired pneumonia and mortality attribute to infection were independent risk factors for CRE meningitis. Conclusion: CRE is one of the most serious drug-resistant bacteria published by World Health Organization (WHO) in 2016, and meningitis/encephalitis caused by CRE is an important sign of the failure of the neurosurgery, which demands the physician's immediate attention. © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 传染病学 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 传染病学 4 区 药学
JCR分区:
出版当年[2017]版:
Q4 PHARMACOLOGY & PHARMACY Q4 INFECTIOUS DISEASES
最新[2023]版:
Q3 INFECTIOUS DISEASES Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [a]Department of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, China
通讯作者:
通讯机构: [a]Department of Clinical Diagnosis Laboratory of Beijing Tiantan Hospital, Capital Medical University, China [*1]Beijing Tiantan Hospital, Capital Medical University, Nansihuan west road NO.119, Fengtai district, Beijing, 100070, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院